Profil

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Staff turnover in EUR1 635 6671 370 9791 293 5231 404 5221 490 588
Staff turnover in EUR1 635 6671 370 9791 293 5231 404 5221 490 588
Akcie denominované v EUR20212022202320242025
Počet vydaných akcií (v milionech)1,001,001,001 241,571,00
Dividenda na akcii2.842.9233.083.16
Zisk na akcii bez emise nových akcií4,933,644,500,386,78
Přehled zisků a ztrát v milionech EUR dle IAS/IFRS20212022202320242025
Obrat27 372,027 085,027 058,028 727,029 448,0
Provozní zisk (EBIT)7 984,65 807,56 390,91 192,79 010,3
Zisk před zdaněním (EBT)8 278,05 814,06 859,0690,09 796,0
Annual net profit/ loss6 225,04 592,05 665,0480,08 510,0
Rozvaha v milionech EUR IAS/IFRS20212022202320242025
Aktiva
Celková běžná aktiva14 772,014 443,016 085,019 173,018 342,0
Celková fixní aktiva53 180,048 728,046 040,039 822,040 681,0
Celková aktiva67 952,063 171,062 125,058 995,059 023,0
Závazky
Celkové krátkodobé závazky11 610,011 237,011 280,012 004,011 813,0
Celkové dlouhodobé závazky35 278,030 725,028 096,027 745,024 591,0
Oprávky celkem0,00,00,00,00,0
Základní kapitál21 064,021 209,022 749,019 246,022 619,0
Celkové závazky67 952,063 171,062 125,058 995,059 023,0
Management:
Jacqueline Barton
Jeffrey Bluestone
Sandra Horning
Ted Love
Anthony Welters
Harish Manwani
Javier Rodriguez
Kelly Kramer
Daniel O'Day
Andrew Dickinson
Cindy Perettie
Deborah H. Telman
Flavius Martin
Johanna Mercier
Jyoti Mehra
MD. PhD Dietmar Berger
Stacey Ma
Představenstvo:
Struktura akcionářů v %:
BlackRock Fund Advisors 5,75
Capital Research & Management Co. (Global Investors) 2,19
Capital Research & Management Co. (World Investors) 3,33
Dodge & Cox 1,95
Fidelity Management & Research Co. LLC 4,55
Geode Capital Management LLC 2,39
SSgA Funds Management, Inc. 4,82
T. Rowe Price Associates, Inc. (IM) 1,95
Vanguard Capital Management LLC 6,50
Vanguard Portfolio Management LLC 2,83
Streubesitz 63,74
Adresa: 333 Lakeside Drive, 94404 Foster City
T: +1-650-574-3000
F: +1-650-522-5853
I: http://www.gilead.com
E: